BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2367694)

  • 1. Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: a graded-response analysis.
    Bentzen SM; Turesson I; Thames HD
    Radiother Oncol; 1990 Jun; 18(2):95-106. PubMed ID: 2367694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy.
    Bentzen SM; Overgaard M
    Radiother Oncol; 1991 Mar; 20(3):159-65. PubMed ID: 1852907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of dose-response relationships for late radiation effects: an analysis of skin telangiectasia and of head and neck morbidity.
    Turesson I
    Radiother Oncol; 1991 Mar; 20(3):149-58. PubMed ID: 1852906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy.
    Safwat A; Bentzen SM; Turesson I; Hendry JH
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):198-204. PubMed ID: 11777639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual variation and dose dependency in the progression rate of skin telangiectasia.
    Turesson I
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1569-74. PubMed ID: 2262383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy.
    Johansen J; Bentzen SM; Overgaard J; Overgaard M
    Radiother Oncol; 1996 Aug; 40(2):101-9. PubMed ID: 8884963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
    Bentzen SM; Overgaard M; Overgaard J
    Eur J Cancer; 1993; 29A(10):1373-6. PubMed ID: 8398261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study.
    Bentzen SM; Thames HD; Overgaard M
    Radiother Oncol; 1989 Jul; 15(3):267-74. PubMed ID: 2772254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin telangiectasia: the influence of radiation dose delivery parameters in the conservative management of early breast cancer.
    Dodwell DJ; Povall J; Gerrard G; Eastwood A; Langlands A
    Clin Oncol (R Coll Radiol); 1995; 7(4):248-50. PubMed ID: 8845324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of skin telangiectasia for late radiation effects in different normal tissues.
    Turesson I; Notter G
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):603-9. PubMed ID: 3084405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up.
    Turesson I; Thames HD
    Radiother Oncol; 1989 Jun; 15(2):169-88. PubMed ID: 2762590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships.
    Turesson I
    Radiother Oncol; 1989 Jul; 15(3):217-26. PubMed ID: 2772250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for late normal tissue complications following radiotherapy for breast cancer.
    Lilla C; Ambrosone CB; Kropp S; Helmbold I; Schmezer P; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
    Breast Cancer Res Treat; 2007 Nov; 106(1):143-50. PubMed ID: 17221151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moist desquamation and telangiectasia in patients treated by postmastectomy irradiation.
    Thames HD
    Radiother Oncol; 1991 Mar; 20(3):207-8. PubMed ID: 1852913
    [No Abstract]   [Full Text] [Related]  

  • 15. The hyfrecator: a treatment for radiation induced telangiectasia in breast cancer patients.
    Rowland Payne CM; Somaiah N; Neal AJ; Glees JP
    Br J Radiol; 2005 Feb; 78(926):143-6. PubMed ID: 15681326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes.
    Giotopoulos G; Symonds RP; Foweraker K; Griffin M; Peat I; Osman A; Plumb M
    Br J Cancer; 2007 Mar; 96(6):1001-7. PubMed ID: 17325707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CD4
    Veldwijk MR; Seibold P; Botma A; Helmbold I; Sperk E; Giordano FA; Gürth N; Kirchner A; Behrens S; Wenz F; Chang-Claude J; Herskind C
    Clin Cancer Res; 2019 Jan; 25(2):562-572. PubMed ID: 30327309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining the evidence for GSTA1 and eNOS genetic effects on risk of radiotherapy-induced telangiectasia.
    Giotopoulos G; Armstrong C; Osman A; Peat I; Symonds RP; Talbot CJ
    Int J Cancer; 2008 Dec; 123(12):2973-4. PubMed ID: 18785208
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulsed dye laser treatment of telangiectasia after radiotherapy for breast carcinoma.
    Ahmad M; Mirza S; Foo IT
    Br J Plast Surg; 1999 Apr; 52(3):236-7. PubMed ID: 10474479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for skin telangiectasia following post-mastectomy electron beam irradiation.
    Huang EY; Chen HC; Wang CJ; Sun LM; Hsu HC
    Br J Radiol; 2002 May; 75(893):444-7. PubMed ID: 12036838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.